The role of platelet CD154 in the modulation in adaptive immunity

被引:0
|
作者
Daniel L. Sprague
Jennifer M. Sowa
Bennett D. Elzey
Timothy L. Ratliff
机构
[1] University of Iowa,Department of Urology
[2] University of Iowa,Medical Scientist Training Program
[3] University of Iowa,Department of Microbiology
[4] University of Iowa,Interdisciplinary Immunology Program
[5] University of Iowa,Holden Comprehensive Cancer Center
来源
Immunologic Research | 2007年 / 39卷
关键词
Platelets; CD154; B cells; T cells; Humoral immunity; Immune regulation;
D O I
暂无
中图分类号
学科分类号
摘要
Platelets’ primary role is hemostasis. However, a growing body of research has demonstrated that platelets are integral to the initiation of an inflammatory response and are potent effector cells of the innate immune response. Activated platelets express CD154, a molecule critical to adaptive immune responses, which has been implicated in platelet-mediated modulation of innate immune responses and inflammation. Recent studies utilizing CD154 knockout mice extend the role of platelet-derived CD154 to the modulation of adaptive immune response by enhancing antigen presentation, improving CD8+ T cell responses, and playing a critical function in T-dependent humoral immunity under physiological conditions. Together these data provide a basis for the expansion of the current paradigm of B cell activation and germinal center formation to include a role for platelets.
引用
收藏
页码:185 / 193
页数:8
相关论文
共 50 条
  • [21] The role of CD154 in organ transplant rejection and acceptance
    Kirk, AD
    Blair, PJ
    Tadaki, DK
    Xu, H
    Harlan, DM
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2001, 356 (1409) : 691 - 702
  • [22] A Protective Role for CD154 in Hepatic Steatosis in Mice
    Villeneuve, Julien
    Lepreux, Sebastien
    Mulot, Audrey
    Berard, Annie M.
    Higa-Nishiyama, Arisa
    Costet, Pierre
    De Ledinghen, Victor
    Bioulac-Sage, Paulette
    Balabaud, Charles
    Nurden, Alan T.
    Rosenbaum, Jean
    Chevet, Eric
    Ripoche, Jean
    HEPATOLOGY, 2010, 52 (06) : 1968 - 1979
  • [23] Inhibition of CD40–CD154 costimulatory pathway by a cyclic peptide targeting CD154
    Ilaria Deambrosis
    Sara Lamorte
    Fulvia Giaretta
    Lorenzo Tei
    Luigi Biancone
    Benedetta Bussolati
    Giovanni Camussi
    Journal of Molecular Medicine, 2009, 87 : 181 - 197
  • [24] A Role for CD154, the CD40 Ligand, in Granulomatous Inflammation
    Villeneuve, Julien
    Desmouliere, Alexis
    Dewitte, Antoine
    Bordeau, Nelly
    Costet, Pierre
    Bassaganyas, Laia
    Fricain, Jean-Christophe
    Ripoche, Jean
    Lepreux, Sebastien
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [25] Platelet - derived CD154 antigen in patients with chronic kidney disease
    Stepniewska, Joanna
    Dolegowska, Barbara
    Chrusciana, Marta
    Golembiewska, Edyta
    Malinowska-Jedraszczyk, Alicja
    Marchelek-Mysliwiec, Malgorzata
    Ciechanowski, Kazimierz
    CLINICAL BIOCHEMISTRY, 2016, 49 (03) : 243 - 247
  • [26] Compartmentalization of platelet derived CD154: Implications for clinical correlation.
    Charafeddine, Ali H.
    Gunay-Aygun, Meral
    Weaver, Timothy A.
    Maynard, Dawn M.
    Agarwal, Avi
    Lwakoshi, Neal
    Gahl, William A.
    Kirk, Allan D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 494 - 494
  • [27] Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion
    Phipps, RP
    Kaufman, J
    Blumberg, N
    LANCET, 2001, 357 (9273): : 2023 - 2024
  • [28] A new CD154 mutation
    Serra, HM
    Baena-Cagnani, CE
    Mariani, AL
    Martin, A
    Garip, EA
    Pesoa, SA
    ALLERGY, 2001, 56 (12) : 1230 - 1231
  • [29] The role of platelet derived soluble CD40L(Scd40I; CD154) in adverse reactions to platelet transfusions
    Blumberg, N
    Gettings, KF
    Turner, C
    Heal, JM
    Phipps, RP
    TRANSFUSION, 2004, 44 (09) : 18A - 18A
  • [30] CD154 (CD40 ligand)
    Schönbeck, U
    Mach, F
    Libby, P
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2000, 32 (07): : 687 - 693